Ontology highlight
ABSTRACT:
SUBMITTER: Bonomo P
PROVIDER: S-EPMC7186263 | biostudies-literature | 2020 Jul
REPOSITORIES: biostudies-literature
Bonomo Pierluigi P Lucidi Sara S Desideri Isacco I Scotti Vieri V Casati Marta M Palomba Annarita A Ciabatti Cinzia C Garlatti Pietro P Massi Daniela D Gallo Oreste O Livi Lorenzo L
Clinical and translational radiation oncology 20200417
Immune checkpoint inhibitors (ICIs) represent a recently introduced class of agents active in head and neck squamous cell carcinoma (HNSCC). For a subgroup of patients with recurrent or metastatic disease, long-term benefit can be achieved: maintaining a sustained response to immunotherapy is therefore a critical factor for its efficacy at an individual level. In analogy to targeted agents, a limited pattern of progression, or "oligoprogression", can occur. For locally recurrent HNSCC, the poten ...[more]